iContraception
source

iContraception

(382)
Price
Free
Category
Medical
Last update
May 03, 2021
Publisher
Javier Alvargonzalez Contact publisher
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
382
Avg rating,
total
⭐4.7
Loading...

Description

1338 chars

This App is intended for health-care providers. It contains recommendations intended to help health-care providers determine the safe use of contraceptive methods among women with various characteristics, habits and medical conditions. Providers can select conditions according to the patient, and the App assigns automatically a category for each method. Generally speaking and with medical criteria, categories 1 and 2 permit the use of a treatment in any case or with some considerations and categories 3 and 4 advise against or forbid its usage. For more information consult this App or its documentation. The recommendations refer to contraceptive methods being used for contraceptive purposes; the recommendations do not consider the use of contraceptive methods for treatment of medical conditions because the eligibility criteria in these cases may differ. The recommendations and all information contained in this App, are based on the document "Medical eligibility criteria for contraceptive use, Fourth edition 2009" published by WHO ("World Health Organization"). Adaptations and modifications to update its contents has been made following the conferences of the "Sociedad Española de Contracepción" (Spanish Society for Contraception) and the CDC document "U.S. Medical Eligibility Criteria for Contraceptive Use, 2010".

Screenshots

https://play-lh.googleusercontent.com/pSeEVwwwNtC0wRHE4AIS6P2Qs_zMoBhz3QOH_HIoyVClIEKQMgmSUjOU1ppj2C1tNA=w720-h310-rwhttps://play-lh.googleusercontent.com/BvBdDZZDkaSzP6didCKenc7jW4FRi2LxQ-66DeuYPc7cv8K75HHBzFiPt9M72yLGZA=w720-h310-rwhttps://play-lh.googleusercontent.com/ggd04QSp6Ze-ZUS-ATljObp3AglcgeLbh87B215jn7Mi6YolKuU0yn3Xv1bPOCswkw=w720-h310-rwhttps://play-lh.googleusercontent.com/Km-hrGxxDZxeLA-tzT7_juItIVMW12r_tv3IkxlqhhCmxSn8HX4W3Vqrs_2rRdqF-rc=w720-h310-rwhttps://play-lh.googleusercontent.com/wkwTPLyC41CXHxH3bmMG8mcE_j13sNycqPCpWEWdTgP_3FRntB0BEsnOSn8wODVV_9U=w720-h310-rwhttps://play-lh.googleusercontent.com/qyhRZENblV9QiVnD9gyG6xsbusudaQpYvVZ6o6QM5oY-x0ZaOvZBvzX6jzgiiUF2Y3-0=w720-h310-rwhttps://play-lh.googleusercontent.com/Jeen5d_ZzurM8i5FR2qrGoSQLsRiDW6TEKNMWN-h2reFdu3AakxRNnQA9jZklJmTcGpn=w720-h310-rw
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster